Meanwhile, brokers have indicated continued confidence in several ASX 200 shares this week.
Let's take a look.
Image source: Getty Images
Santos Ltd (ASX: STO)
The Santos share price is $8.55, up 0.3% today.
Over the past month, this ASX 200 energy share has risen 12%.
Citi renewed its buy rating on Santos shares on Tuesday.
The broker raised its 12-month price target from $9 to $9.35.
This suggests a potential 9% upside ahead.
Goodman Group (ASX: GMG)
The Goodman Group share price is $26.92, down 0.9% today.
Over the past month, this ASX 200 property share has fallen 10%.
UBS reiterated its buy rating on Goodman shares today with a price target of $33.66.
This implies potential capital gains of 25% ahead.
Telstra Group Ltd (ASX: TLS)
The Telstra share price is $4.81, up 0.5% today.
Over the past month, this ASX telco share has declined 4%.
Citi renewed its buy recommendation with a 12-month price target of $5.25 this week.
This implies a potential 10% upside ahead.
Pls Group Ltd (ASX: PLS)
The PLS Group share price is $4.84, down 3.5% today.
Over the past month, this ASX 200 lithium share has lifted 2%.
Citi renewed its buy rating on PLS Group shares on Wednesday.
The broker increased its target price from $5 to $5.70.
This implies potential capital growth of 17% over the next year.
AMP Ltd (ASX: AMP)
The AMP share price is $2.48, down 0.4% on Thursday.
Over the past month, this ASX 200 financial share has risen 5%.
Jefferies renewed its buy rating on AMP shares yesterday.
The broker raised its target from $2.55 to $2.77.
This implies potential capital growth of 12% over the next year.
Life360 Inc (ASX: 360)
The Life360 share price is $19.43, down 1% today.
Over the past month, this ASX 200 tech share has fallen 34%.
Citi renewed its buy rating on Life360 shares with a $28.80 target this week.
This suggests a potential 49% upside ahead.
Pro Medicus Ltd (ASX: PME)
This ASX 200 healthcare share has fallen 6% over the past month.
Citi reiterated its buy rating on Pro Medicus shares today.
The broker decreased its price target from $240 to $225.
This still implies a healthy potential upside of 35% ahead.
Pro Medicus is one of 40 ASX shares going ex-dividend this week.
Sigma Healthcare Ltd (ASX: SIG)
The Sigma Healthcare share price is $2.65, down 0.9% today.
Over the past month, this ASX 200 healthcare share has fallen 11%.
Macquarie renewed its buy rating on Sigma Healthcare shares on Monday.
The broker has a 12-month price target of $3.20.
This suggests a potential 21% upside ahead.
ANZ Group Holdings Ltd (ASX: ANZ)
The ANZ share price is $36.39, down 1.1% today.
Over the past month, this ASX 200 bank share has fallen 2%.
Citi reiterated its buy rating on ANZ shares with a $39.25 target this week.
This implies a potential 7% upside ahead.
ASX 200 bank shares weakened last month amid investor concerns over a housing credit downturn.
ANZ shares fared best as the bank continues to benefit from a reset under CEO Nuno Matos.
